Y-mAbs Therapeutics, Inc. – ‘8-K’ for 2/17/21 – ‘EXCEL’

On:  Friday, 2/19/21, at 6:01am ET   ·   For:  2/17/21   ·   Accession #:  1104659-21-25436   ·   File #:  1-38650

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML    713K 
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    178K 
 3: EX-5.1      Opinion of Counsel re: Legality                     HTML     16K 
 4: EX-10.1     Material Contract                                   HTML    141K 
 5: EX-99.1     Miscellaneous Exhibit                               HTML     14K 
 6: EX-99.2     Miscellaneous Exhibit                               HTML     14K 
11: R1          Cover                                               HTML     48K 
13: XML         IDEA XML File -- Filing Summary                      XML     16K 
10: XML         XBRL Instance -- tm217037d1_8k_htm                   XML     16K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 8: EX-101.LAB  XBRL Labels -- ymab-20210217_lab                     XML     97K 
 9: EX-101.PRE  XBRL Presentations -- ymab-20210217_pre              XML     65K 
 7: EX-101.SCH  XBRL Schema -- ymab-20210217                         XSD     13K 
14: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    34K 
15: ZIP         XBRL Zipped Folder -- 0001104659-21-025436-xbrl      Zip    510K 

‘EXCEL’   —   IDEA Workbook of Financial Reports

This is an IDEA Workbook.

Download this Microsoft® Excel® .xlsx workbook

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/24  Y-mAbs Therapeutics, Inc.         10-K       12/31/23  101:10M                                    Toppan Merrill Bridge/FA
 3/30/23  Y-mAbs Therapeutics, Inc.         10-K       12/31/22  106:10M                                    Toppan Merrill Bridge/FA
 3/01/22  Y-mAbs Therapeutics, Inc.         10-K       12/31/21   93:10M                                    Toppan Merrill Bridge/FA
 3/01/21  Y-mAbs Therapeutics, Inc.         10-K       12/31/20   84:9.6M                                   Toppan Merrill Bridge/FA